News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Dexus Finance Pty Limited: Portfolio valuation update and estimated distribution details - 30 June 2024
Dexus Finance Pty Limited announces portfolio valuation update: decrease of circa $1.3 billion (9.0%) in book values for the six months to 30 June 2024. Estimated distribution details available on 20 August 2024 -
COMMUNIQUÉ DE PRESSE
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA -
-
-
-
COMMUNIQUÉ DE PRESSE
Perk Labs Inc. Provides Update on Status of MCTO
Perk Labs Inc. provides an update on the management cease trade order granted by the BC Securities Commission, extending it until July 4, 2024, due to delays in financial filings. The Company continues to work on completing the annual filings
